Cytokine-neuroantigen fusion proteins as a new class of tolerogenic, therapeutic vaccines for treatment of inflammatory demyelinating disease in rodent models of multiple sclerosis.
Mannie MD, Blanchfield LJ, Islam TSM, Abbott DJ
Front Immunol. 2012; 3:255. Epub 2012 Aug 20. PMID: 22934095.Abstract